While the past few days haven`t been ideal for everyone SNPK is up 100% from its low last week, and independent research firm has kept their target and recommendation unchanged:
$9 target price and a STRONG BUY recommendation remains in play!
They must see tremendous potential in the company thanks to all the amazing alliances it is forming with Fortune 500 companies.
We could be in for a big surprise in the days and weeks to come as SNPK continues executing on its plan of actione.
We`d like to share a few youtube videos with our members:
Clotamin ad that began airing on TV throughout the country a few weeks ago: http://youtu.be/_luXH1u8TWU
MrPennyStocks gives us a full brief on SNPK: http://youtu.be/cEb15EWu7t4
MrPennyStocks comments on SNPK dips: http://youtu.be/e2nWqnbPRlYNBA legend Paul Silas, the Portland Trail Blazers, the Arizona Cardinals, and the Soul Football Team are all still in the mix with Clotamin and SNPK.
Moreover national rollouts for Clotamin are imminent, and it will be at hundreds of stores very soon. That`s on top of the fact that Clotamin is already available nationwide at Walgreens online.
Clotamin is now also available in a couple countries at Amazon online! Amazon is the world`s largest online retailer! This could be absolutely massive for the company!SNPK is still very hot and could completely regain its attraction very soon!
Investor Central.com is a leading financial communications firm, that provides free alerts on stocks that show various activities, based on volume, news, volatitlity.
This release contains “forward-looking” statements as that term is defined by Section 27A of the Securities Act of 1933, as amended, (the “Securities Act” ) and Section 21E of the Securities Exchange Act of 1934, as amended, (the “Exchange Act” ). All statements that are included in this release other than statements of historical fact are “forward-looking” statements. Although management believes that the expectations reflecting in these forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Important factors could cause actual results to differ materially from the expectations as disclosed herein, including without limitation, in conjunction with these forward-looking statements contained in this release.
Disclaimer: Investor Central.com “(Investor Central.com)” is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security.
Investor Central.com profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of Investor Central.com and are subject to change without notice. Information in this release is derived from a variety of sources including that company`s publicly disseminated information, third parties and Investor Central.com research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investor Central.com disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies ` discussed in this release is highly speculative and carries a high degree of risk. Investor Central.com is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in Investor Central.com profiled stocks.
Please be advised that Investor Central.com is often compensated for issuing press release, profiles or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating Investor Central.com`s statements regarding a company.
Investor Central.com`s officers and directors reserve the right to buy additional shares of the company discussed in this opinion and may profit in the event those shares rise in value. When Investor Central.com receives free trading shares as compensation for a profiled company, Investor Central.com may sell part or all of any such shares during the period in which Investor Central.com is performing such services. Investor Central.com will also disclose any compensenation.
Disclaimer: http://Investor Central.com/disclaimer.htm
Contact Email: info@Investor Central.com
See Investor Central’s website for full disclaimer. Investor Central may have received compensation for stock picks.
View the original here: